accelerated-phase mpns: pathophysiology, treatment approaches and ongoing clinical trials
Published 1 year ago • 219 plays • Length 4:22Download video MP4
Download video MP3
Similar videos
-
1:35
novel approaches being explored for patients with accelerated and blast-phase mpns
-
2:43
the management of advanced phase mpns
-
1:23
insights into the management and treatment of accelerated/blast-phase mpns
-
1:00
how genomic testing has influenced treatment approaches and clinical trial design in mpns
-
1:14
an overview of the current and future treatment landscape for mpns
-
1:50
criteria for the diagnosis of accelerated/blast phase mpn and challenges clinicians may face
-
2:45
an insight into clinical risk factors for progression in mpns
-
1:03
an insight into the sequencing of immunotherapies in adults with all
-
15:45
updates on the use of ropeginterferon in the treatment of mpns
-
13:13
precision medicine in myeloproliferative neoplasms
-
4:35
updated safety & efficacy data from manifest-2: pelabresib plus ruxolitinib for myelofibrosis
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
1:51
checkpoint inhibition in the treatment of mpns
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
2:06
how the mpn field has evolved over the years: novel agents, trials, and more
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
1:07
the second revision of the international staging system for os in mm
-
1:43
potential of next-generation sequencing in the nhs for patients with mpns
-
0:48
promising therapeutic targets in mpns
-
4:17
treatment sequencing and ongoing clinical trials in anemic myelofibrosis
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
3:50
changing clinical trial endpoints in mpns & the link between hematopoietic fitness and outcomes